Evidence map›Paper›PMID 40317071›Full record

SynthesisRespiratory research2025

Purpose in life and lung function: an individual-participant meta-analysis of six cohort studies.

Angelina R Sutin, Yannick Stephan, Martina Luchetti, Justin Brown, Tiia Kekäläinen, André Hajek, Brice Canada, Sébastien Kuss, Antonio Terracciano

Abstract readMeta-Analysis
In one paragraph

Synthesis in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angelina R SutinFlorida State University College of Medicine, 1115 W. Call Street, Tallahassee, FL, 32306, USA. angelina.sutin@med.fsu.edu.
Yannick StephanEuromov, University of Montpellier, Montpellier, France.
Martina LuchettiFlorida State University College of Medicine, 1115 W. Call Street, Tallahassee, FL, 32306, USA.
Justin BrownFlorida State University College of Medicine, 1115 W. Call Street, Tallahassee, FL, 32306, USA.
Tiia KekäläinenLaurea University of Applied Sciences, Vantaa, Finland.
André HajekDepartment of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany.
Brice CanadaL-VIS, University of Lyon 1, Lyon, France.
Sébastien KussL-VIS, University of Lyon 1, Lyon, France.
Antonio TerraccianoFlorida State University College of Medicine, 1115 W. Call Street, Tallahassee, FL, 32306, USA.

Funding

HRS Yrs29-34: Y33 SSA CoFundingU01AG009740 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jessica Faul, KENNETH M LANGA · 1990 to 2026
$555.8M
The National Health and Trends StudyU01AG032947 · NIA · JOHNS HOPKINS UNIVERSITY · PI VICKI A. FREEDMAN, JENNIFER ANN SCHRACK · 2008 to 2026
$169.4M
University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Project-001R01AG017644 · NIA · UNIVERSITY OF LONDON INST OF NEUROLOGY · PI Andrew Steptoe · 2000 to 2026
$56.2M
STATISTICS COREP01AG020166 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI RYFF, CAROL D. · 2002 to 2015
$50.6M
ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
WISCONSIN LONGITUDINAL STUDY--SIBLING INTERVIEWS (1)R01AG009775 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI HERD, PAMELA · 1991 to 2012
$23.4M
WORK, HEALTH, AND WELL-BEINGP01AG021079 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI PALLONI, ALBERTO B. · 2002 to 2011
$14.2M
Aging Together: Brothers and Sisters of the Wisconsin Longitudinal StudyR01AG033285 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI HERD, PAMELA, WARREN, JOHN ROBERT · 2009 to 2013
$11.8M
WIHS INTENSIVE PHARMACOKINETIC STUDY (IPS)M01RR023942 · NCRR · GEORGETOWN UNIVERSITY · PI FEDEROFF, HOWARD J. · 2007 to 2009
$6.9M
Purpose in life: Mechanisms to support healthier cognitive aging and reduce risk of Alzheimer's diseaseR01AG074573 · NIA · FLORIDA STATE UNIVERSITY · PI SUTIN, ANGELINA R · 2021 to 2025
$3.5M
NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1 TR002373NCRR NIH HHS M01 RR000865NCRR NIH HHS M01 RR023942NIA NIH HHS P01 AG020166NIA NIH HHS P01 AG021079NIA NIH HHS R01 AG009775NIA NIH HHS R01 AG017644NIA NIH HHS R01 AG033285NIA NIH HHS R01 AG041868NIA NIH HHS R01 AG074573NIA NIH HHS R01AG074573NIA NIH HHS U01 AG009740NIA NIH HHS U01 AG032947
6 · The paper itself

Abstract

backgroundPurpose in life is a psychological resource associated with better health outcomes across adulthood. It is unknown whether it is related to lung function, a key marker of health and longevity. We evaluate the replicability and generalizability of the cross-sectional association between purpose in life and lung function and whether purpose in life is associated with lower risk of developing poor lung function over time.

methodsParticipants were from six cohort studies with public data: Health and Retirement Study, Midlife in the United States study, Wisconsin Longitudinal Study, National Health and Aging Trends Study, English Longitudinal Study of Ageing, and Survey of Health, Ageing and Retirement in Europe (total N = 85,190). Participants reported on their purpose in life, and staff measured their peak expiratory flow with either a peak flow meter or a spirometer. Four cohorts (N = 11,595) had longitudinal assessments of lung function over up to 12 years. Linear regression was used to test the cross-sectional association between purpose and continuous lung function. Cox regression was used to test the association between purpose and risk of developing predicted lung function < 80% over time, a dichotomous outcome that categorized lung function into performance less than 80% of predicted function (= 1) and at least 80% of predicted function (= 0).

resultsIn each cohort and aggregated in a random-effects meta-analysis, higher purpose in life was associated with better peak expiratory flow (meta-analytic effect = 0.07, p <.001). The association was generally similar across sociodemographic groups (e.g., age, sex). Every standard deviation higher purpose in life was associated with a 10% reduced risk of developing poor lung function over time (meta-analytic hazard ratio = 0.91, 95% confidence interval = 0.88, 0.94, p <.001). These associations were attenuated but remained significant accounting for behavioral and clinical risk factors.

conclusionsPurpose in life is associated with healthier lung function, with evidence of replicability and generalizability, and with lower risk of developing poor lung function over time. Lung function may be one mechanism between purpose in life and healthier outcomes in older adulthood. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

AgingLungCohort StudiesCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleRespiratory Function TestsLongitudinalLung functionMeta-analysisPulmonary functionPurpose in lifeWell-being

Identifiers

PMID40317071
PMCPMC12049041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.